Almanac 2013: novel non-coronary cardiac interventions

[1] Meier P, Timmis A. Almanac 2012: interventional cardiology.10.5152/akd.2013.049Search in Google Scholar

Anadolu Kardiyol Derg 2012;13:91-101.Search in Google Scholar

[2] Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004;110:1042-6.10.1161/01.CIR.0000140263.20897.42Search in Google Scholar

[3] European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, et al.Search in Google Scholar

Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.Search in Google Scholar

[4] Gallagher AM, Rietbrock S, Plumb J, et al. Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis? J Thromb Haemost 2008;6:1500-6.10.1111/j.1538-7836.2008.03059.xSearch in Google Scholar

[5] Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol 2003;42:1253-8.10.1016/S0735-1097(03)00954-9Search in Google Scholar

[6] MEMBERS WC, Bonow RO, Carabello BA, et al. 2008Search in Google Scholar

Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998Search in Google Scholar

Guidelines for the Management of PatientsWith Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.Search in Google Scholar

Circulation 2008;118:e523-661.Search in Google Scholar

[7] Khattab AA, Meier B. Transcatheter left atrial appendage exclusion, gold or fool’s gold? Eur Heart J Suppl 2010;12:E35-40.10.1093/eurheartj/suq008Search in Google Scholar

[8] Sousa JE, Costa MA, Tuzcu EM, et al. New frontiers in interventional cardiology. Circulation 2005;111:671-81.10.1161/01.CIR.0000153802.70682.22Search in Google Scholar

[9] Munkholm-Larsen S, Cao C, Yan TD, et al. Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review. Heart 2012;98:900-7.10.1136/heartjnl-2011-301256Search in Google Scholar

[10] Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-42.10.1016/S0140-6736(09)61343-XSearch in Google Scholar

[11] Reddy VY, Doshi SK, Sievert H, et al. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013;127:720-9.10.1161/CIRCULATIONAHA.112.11438923325525Search in Google Scholar

[12] Reddy VY, Holmes D, Doshi SK, et al. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123:417-24.10.1161/CIRCULATIONAHA.110.97644921242484Search in Google Scholar

[13] Massumi A, Chelu MG, Nazeri A, et al. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation. Am J Cardiol 2013;111:869-73.10.1016/j.amjcard.2012.11.06123312129Search in Google Scholar

[14] Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol 2012;59:923-9.10.1016/j.jacc.2011.11.02822381428Search in Google Scholar

[15] Bass JL. Transcatheter occlusion of the left atrial appendage - experimental testing of a new Amplatzer device.Search in Google Scholar

Catheter Cardiovasc Interv 2010;76:181-5.Search in Google Scholar

[16] Fox BD, Kahn SR, Langleben D, et al. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ 2012;345:e7498.10.1136/bmj.e7498349655323150473Search in Google Scholar

[17] Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.Search in Google Scholar

Eur Heart J 2012;33:2719-47.Search in Google Scholar

[18] Iung B, Vahanian A. Degenerative calcific aortic stenosis: a natural history. Heart 2012;98:iv7-13.10.1136/heartjnl-2012-30239523143128Search in Google Scholar

[19] Alfieri O, Denti P. Alfieri stitch and its impact on mitral clip. Eur J Cardiothorac Surg 2011;39:807-8.10.1016/j.ejcts.2011.01.01721353584Search in Google Scholar

[20] Delgado V, Kapadia S, Marsan NA, et al. Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart 2011;97:1704-14.10.1136/hrt.2011.22778521949284Search in Google Scholar

[21] Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST phase I clinical trial. J Am Coll Cardiol 2005;46:2134-40.10.1016/j.jacc.2005.07.06516325053Search in Google Scholar

[22] Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.10.1056/NEJMoa100935521463154Search in Google Scholar

[23] Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J Am Coll Cardiol 2012;59:130-9.10.1016/j.jacc.2011.08.06722222076Search in Google Scholar

[24] Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.10.1016/j.jacc.2009.03.07719679246Search in Google Scholar

[25] Tamburino C, Ussia GP, Maisano F, et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur Heart J 2010;31:1382-9.10.1093/eurheartj/ehq051Search in Google Scholar

[26] Sürder D, Pedrazzini G, Gaemperli O, et al. Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry.Search in Google Scholar

Heart 2013;99:1034-40.Search in Google Scholar

[27] Kar S, Rinaldi M, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: demographics and procedural outcomes. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.Search in Google Scholar

[28] Rinaldi MJ, Kar S, Lim DS, et al. EVEREST II REALISM: a continued access study to evaluate the safety and effectiveness of the MitraClip device: analysis of a 6 month patient cohort. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.Search in Google Scholar

[29] Sarkar K, Ussia GP, Cammalleri V, et al. Quality of life of high risk patients following percutaneous mitral valve repair with the MitraClip system. Society for Cardiovascular Angiography and Interventions (SCAI) 2011 Scientific Sessions; Baltimore, 2011.Search in Google Scholar

[30] Gaemperli O, Moccetti M, Surder D, et al. Acute haemodynamic changes after percutaneous mitral valve repair: relation to mid-term outcomes. Heart 2012;98:126-32.10.1136/heartjnl-2011-300705Search in Google Scholar

[31] Samad Z, Kaul P, Shaw LK, et al. Impact of early surgery on survival of patients with severe mitral regurgitation.Search in Google Scholar

Heart 2011;97:221-4.10.1136/hrt.2010.202432Search in Google Scholar

[32] Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11.10.1016/S0140-6736(06)69208-8Search in Google Scholar

[33] Rosenhek R. Almanac 2011: valvular heart disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Heart 2011;97:2007-17.10.1136/heartjnl-2011-30139622116890Search in Google Scholar

[34] Sinning J-M, Werner N, Nickenig G, et al. Transcatheter aortic valve implantation: the evidence. Heart 2012;98:iv65-72.10.1136/heartjnl-2012-30239323143127Search in Google Scholar

[35] Agnihotri A. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: executive summary. J Thorac Cardiovasc Surg 2012;144:534-7.10.1016/j.jtcvs.2012.07.02122898502Search in Google Scholar

[36] Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6. 10.1136/heartjnl-2011-30044422076021Search in Google Scholar